Looks like SGH dragging down ICHR and others. I added some ICHR in the $21's. Guess the SGH guidance could have been more blockbuster, but still looks pretty good. And while SGH has more than doubled over the past year (and thus more susceptible to a pullback)...ICHR is nearly unchanged vs. a year ago despite the huge earnings increases.